NEOGEN CORP
BioSniper Score
Based on 4 of 6 signals
Market Cap
$2.03B
Cash Runway
8.5 mo
Lead Asset
neogen one
Next Catalyst
—
Tracking 1 pipeline candidate for NEOGEN CORP · Updated within the last hour.
Go deeper on NEOGEN CORP with Spotter
Ask follow-up questions and run a full multi-agent deep dive on NEOG — live, with citations.
Score breakdownBased on 4 of 6 signals · derived from public data
8.5 months
D/E 0.60 · 0% dilution
No tracked pipeline phase
1 candidate
No upcoming catalysts tracked
4 buys · 0 sells (180d)
Key Financialsas of February 28, 2026
Cash
$159.9M
Quarterly Burn
$102.3M
Revenue
$211.2M
Free Cash Flow
$22.7M
Total Liabilities
$1.26B
Shareholders Equity
$2.10B
Current Ratio
3.92
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| neogen one | — |
Commercialization & Governance
Commercialization
- Launch Markets
- U.S.U.K.EuropeMiddle EastAfricaIndiaMexicoGuatemalaBrazilArgentinaChileUruguayColombiaJapanKoreaThailandChinaAustraliaNew ZealandCanada
- Sales Force Size
- 975
- Commercial Strategy
- Growth strategy consisting of: (i) increasing sales of existing products; (ii) introducing innovative products and services; (iii) growing international sales; and (iv) acquiring businesses and forming strategic alliances.
Governance
- Board Size
- 10
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
309
Total value held
$2.10B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 32,621,005 | $303.0M |
| vanguard capital management llc | 19,130,092 | $177.7M |
| vanguard portfolio management llc | 12,832,264 | $119.2M |
| dimensional fund advisors lp | 9,132,021 | $84.8M |
| ing groep nv | 8,904,300 | $82.7M |
| state street corp | 8,590,344 | $79.8M |
| mackenzie financial corp | 7,803,226 | $72.5M |
| neuberger berman group llc | 7,751,718 | $72.0M |
| hudson bay capital management lp | 6,500,180 | $60.4M |
| gates capital management, inc. | 6,258,649 | $58.1M |
Showing top 10 of 309 institutional holders of NEOGEN CORP. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of NEOGEN CORP?
Mr. Mikhael Nassif is the chief executive officer of NEOGEN CORP (NEOG).
Where is NEOGEN CORP headquartered?
NEOGEN CORP (NEOG) is headquartered in Lansing, MI, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on NEOGEN CORP
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.